Progyny, Inc. 8-K

What Happened

• Progyny, Inc. (PGNY) filed a Form 8-K on May 26, 2026, disclosing that its Board of Directors approved a share repurchase program to buy back up to $200 million of common stock. The program will be funded from the company’s available cash balances and was announced by CEO Peter Anevski.

Key Details

• Approved repurchase amount: up to $200,000,000.
• Funding source: available cash balances.
• Repurchase methods: open-market purchases, including under Rule 10b5-1 trading plans; timing, amount and prices are at the Company’s discretion.
• Program may be suspended or discontinued at any time; no assurance as to number of shares repurchased or purchase prices.

Why It Matters

• A share repurchase program can reduce the number of shares outstanding, which may boost earnings per share and return capital to shareholders if the Company executes buys.
• This filing signals the Board is allocating cash for potential buybacks, but it is not a commitment to repurchase any specific amount — purchases depend on market conditions and management’s discretion.
• Investors should weigh the potential for buybacks against the Company’s cash needs and overall financial strategy; monitor future disclosures for actual repurchase activity.